Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (33)
  • Open Access

    RETRACTION

    Retraction: MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase

    Oncology Research Editorial Office

    Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.077270 - 30 December 2025

    Abstract This article has no abstract. More >

  • Open Access

    REVIEW

    The Versatile Role of Period Circadian Regulators (PERs) in Oral Squamous Cell Carcinoma

    Mei Huang, Zhenyu Zhang, Yuqi Luo, Yuqi Wu, Dan Pan, Yu Zhou*, Xiaobo Luo, Yuchen Jiang*

    BIOCELL, Vol.49, No.6, pp. 961-980, 2025, DOI:10.32604/biocell.2025.062918 - 24 June 2025

    Abstract This review explores the pivotal role of circadian rhythm regulators, particularly the PER genes, in Oral Squamous Cell Carcinoma (OSCC). As key constituents of the biological clock, PERs exhibit a downregulated expression pattern in OSCC, and the expression levels of PERs in OSCC patients are correlated with a favorable prognosis. PERs impact the occurrence and development of OSCC through multiple pathways. In the regulation of cell proliferation, they can function not only through cell cycle regulation but also via metabolic pathways. For example, PER1 can interact with receptors for activated C kinase 1 (RACK1) and… More >

  • Open Access

    ARTICLE

    Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?

    THAINá RODRIGUES1,2, PATRíCIA CANDIDO1,3, FERES CAMARGO MALUF1, POLIANA ROMãO1, CAROLINA MIE MIOSHI1, VANESSA RIBEIRO GUIMARãES1, JULIANA ALVES DE CAMARGO1, KARINA SERAFIM DA SILVA1,4, GABRIEL ARANTES DOS SANTOS1, IRAN AMORIM SILVA1, KATIA RAMOS MOREIRA LEITE1, WILLIAM C. NAHAS5, SABRINA T. REIS1,3, RUAN PIMENTA1,6, NAYARA IZABEL VIANA1,7,*

    Oncology Research, Vol.33, No.6, pp. 1377-1382, 2025, DOI:10.32604/or.2025.055306 - 29 May 2025

    Abstract Objectives: Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two… More >

  • Open Access

    RETRACTION

    Retraction: miR-641 functions as a tumor suppressor by targeting MDM2 in human lung cancer

    Oncology Research Editorial Office

    Oncology Research, Vol.33, No.3, pp. 737-737, 2025, DOI:10.32604/or.2024.056910 - 28 February 2025

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    Melanoma cell line-derived exosomal miR-424-5p: a key promoter of angiogenesis through LATS2 interaction

    JUNWEI DU, QIANG ZHANG, JING ZHANG, MAIERDANJIANG MAIHEMUTI, HAIYANG HE, RENBING JIANG*

    Oncology Research, Vol.33, No.2, pp. 357-367, 2025, DOI:10.32604/or.2024.050878 - 16 January 2025

    Abstract Objectives: Melanoma is a highly aggressive and metastatic form of cancer, and the role of exosomal microRNAs (miRNAs) in its progression remains largely unexplored. This study aimed to investigate the effects of melanoma cell-derived exosomal miR-424-5p on angiogenesis and its underlying mechanisms. Methods: Exosomes were isolated from melanoma cell lines A375 and A2058, and their effects on the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells (HUVECs) were examined. The interaction between miR-424-5p and its target gene, large tumor suppressor kinase 2 (LATS2), was analyzed using luciferase reporter assays and functional experiments. In vivo,… More >

  • Open Access

    RETRACTION

    Retraction: Function of miR-152 as a tumor suppressor in human breast cancer by targeting PIK3CA

    Oncology Research Editorial Office

    Oncology Research, Vol.32, No.10, pp. 1675-1676, 2024, DOI:10.32604/or.2024.056889 - 18 September 2024

    Abstract This article has no abstract. More >

  • Open Access

    REVIEW

    The role of tazarotene-induced gene 1 in carcinogenesis: is it a tumor suppressor gene or an oncogene?

    CHUN-HUA WANG1,2, LU-KAI WANG3, RONG-YAUN SHYU4, FU-MING TSAI5,*

    BIOCELL, Vol.48, No.9, pp. 1285-1297, 2024, DOI:10.32604/biocell.2024.053746 - 04 September 2024

    Abstract Tazarotene-induced gene 1 (TIG1) is induced by a derivative of vitamin A and is known to regulate many important biological processes and control the development of cancer. TIG1 is widely expressed in various tissues; yet in many cancer tissues, it is not expressed because of the methylation of its promoter. Additionally, the expression of TIG1 in cancer cells inhibits their growth and invasion, suggesting that TIG1 acts as a tumor suppressor gene. However, in some cancers, poor prognosis is associated with TIG1 expression, indicating its protumor growth characteristics, especially in promoting the invasion of inflammatory breast cancer More >

  • Open Access

    RETRACTION

    Retraction: miR-148b Functions as a Tumor Suppressor by Targeting Endoplasmic Reticulum Metallo Protease 1 in Human Endometrial Cancer Cells

    Oncology Research Editorial Office

    Oncology Research, Vol.32, No.8, pp. 1379-1379, 2024, DOI:10.32604/or.2024.055034 - 17 July 2024

    Abstract This article has no abstract. More >

  • Open Access

    ARTICLE

    miR-30a-5p/PHTF2 axis regulates the tumorigenesis and metastasis of lung adenocarcinoma

    LIJUAN ZHANG1,#, QINGYIN MENG2,#, LI ZHUANG1, QUAN GONG1, XIANDA HUANG3, XUEQIN LI1, SHIJUAN LI1, GUOQIN WANG4, XICAI WANG5,*

    BIOCELL, Vol.48, No.4, pp. 581-590, 2024, DOI:10.32604/biocell.2024.047260 - 09 April 2024

    Abstract Background: Lung adenocarcinoma is a very pervasive histological form of lung cancers, and inhibiting metastasis is crucial for effective treatment. In this investigation, we explored the functional interaction of miR-30a-5p and the putative transcription factor 2 of the homeodomain (PHTF2) in dictating the aggressiveness and metastasis of lung adenocarcinoma. Method: We collected clinical samples to evaluate the expression patterns of miR-30a-5p and PHTF2 in lung adenocarcinoma along with normal tissues. Cellular experiments including cell count kit (CCK)-8 growth assay, apoptosis analysis, migration and invasion examinations were performed to assess the aggressiveness of lung adenocarcinoma cells.… More > Graphic Abstract

    miR-30a-5p/PHTF2 axis regulates the tumorigenesis and metastasis of lung adenocarcinoma

  • Open Access

    ARTICLE

    Silencing ribosomal protein L4 enhances the inhibitory effects of triptolide on non-small cell lung cancer cells by disrupting the mouse double minute 2 protein–P53 tumor suppressor pathway

    NAN TANG1,#, YAJING ZHAN1,#, JIAYAN MAO2,#, ANKANG YIN1, WEI WANG3,*, JUAN WANG3,*

    BIOCELL, Vol.47, No.9, pp. 2009-2026, 2023, DOI:10.32604/biocell.2023.029269 - 28 September 2023

    Abstract Non-small cell lung cancer (NSCLC) is a malignant tumor with high incidence worldwide. Triptolide (TP), extracted from Tripterygium wilfordii Hook F, exhibits potent broad-spectrum antitumor activity. Although some mechanisms through which TP inhibits NSCLC are well understood, those that involve ribosomal proteins remain yet to be understood. In this study, the transcriptome and proteome were integrated and analyzed. Our data indicated ribosomal protein L4 (RPL4) to be a core hub protein in the protein-protein interaction network. RPL4 is overexpressed in NSCLC tissues and cells. Transfection with siRPL4 or TP treatment alone arrested the cell cycle in More > Graphic Abstract

    Silencing ribosomal protein L4 enhances the inhibitory effects of triptolide on non-small cell lung cancer cells by disrupting the mouse double minute 2 protein–P53 tumor suppressor pathway

Displaying 1-10 on page 1 of 33. Per Page